Literature DB >> 34176015

The Indian Society for Bone and Mineral Research (ISBMR) position statement for the diagnosis and treatment of osteoporosis in adults.

Sanjay K Bhadada1, Manoj Chadha2, Usha Sriram3, Rimesh Pal4, Thomas V Paul5, Rajesh Khadgawat6, Ameya Joshi7, Beena Bansal8, Nitin Kapoor5, Anshita Aggarwal9, Mahendra K Garg10, Nikhil Tandon6, Sushil Gupta11, Narendra Kotwal12, Shriraam Mahadevan13, Satinath Mukhopadhyay14, Soham Mukherjee4, Subhash C Kukreja15, Sudhaker D Rao16, Ambrish Mithal17.   

Abstract

The Indian Society for Bone and Mineral Research (ISBMR) has herein drafted clinical practice guidelines for the diagnosis and management of osteoporosis for the people of India. Implementation of the position statement in clinical practice is expected to improve the overall care of patients with osteoporosis in India.
PURPOSE: In India, osteoporosis is a major public health problem. However, in the absence of any robust regional guidelines, the screening, treatment, and follow-up of patients with osteoporosis are lagging behind in the country.
METHODS: The Indian Society for Bone and Mineral Research (ISBMR), which is a multidisciplinary group of physicians, researchers, dietitians, and epidemiologists and who study bone and related tissues, in their annual meeting, drafted the guidelines for the diagnosis and management of osteoporosis that would be appropriate in a resource constraint setting like India.
RESULTS: Diagnosis of osteoporosis can be made in a patient with minimal trauma fracture without the aid of any other diagnostic tools. In others, bone mineral density measured by dual-energy X-ray absorptiometry remains the modality of choice. Data indicates that osteoporotic fractures occur at an earlier age in Indians than in the West; hence, screening for osteoporosis should begin at an earlier age. FRAX can be used for fracture risk estimation; however, it may underestimate the risk of future fractures in our population and still needs validation. Maintaining optimum serum 25-hydroxyvitamin D levels is essential, which, in most cases, would require regular vitamin D supplementation. Pharmacotherapy should be guided by the presence/absence of vertebral/hip fractures or the severity of risk based on clinical factors, although bisphosphonates remain the first choice in most cases. Regular follow-up is essential to ensure adherence and response to therapy.
CONCLUSIONS: Implementation of the position statement in clinical practice is expected to improve the overall care of patients with osteoporosis in India.

Entities:  

Keywords:  Fracture prevention; Guidelines; ISBMR; India; Osteoporosis

Mesh:

Substances:

Year:  2021        PMID: 34176015     DOI: 10.1007/s11657-021-00954-1

Source DB:  PubMed          Journal:  Arch Osteoporos            Impact factor:   2.617


  59 in total

1.  Bone health in healthy Indian population aged 50 years and above.

Authors:  R K Marwaha; N Tandon; M K Garg; R Kanwar; A Narang; A Sastry; A Saberwal; K Bhadra; A Mithal
Journal:  Osteoporos Int       Date:  2011-01-27       Impact factor: 4.507

2.  Bone status of women over 40 years of age from two socioeconomic strata.

Authors:  Sujata V Vaidya; Veena H Ekbote; Anuradha V Khadilkar; Shashi A Chiplonkar; Deepa Pillay; Uma Divate
Journal:  Endocr Res       Date:  2011-10-11       Impact factor: 1.720

3.  Bone status of Indian women from a low-income group and its relationship to the nutritional status.

Authors:  Veena Shatrugna; Bharati Kulkarni; P Ajay Kumar; K Usha Rani; N Balakrishna
Journal:  Osteoporos Int       Date:  2005-06-15       Impact factor: 4.507

4.  Low bone mass in urban Indian women above 40 years of age: prevalence and risk factors.

Authors:  Nidhi Kadam; Shashi Chiplonkar; Anuradha Khadilkar; Uma Divate; Vaman Khadilkar
Journal:  Gynecol Endocrinol       Date:  2010-09-17       Impact factor: 2.260

5.  Bone density and fracture risk in men.

Authors:  L J Melton; E J Atkinson; M K O'Connor; W M O'Fallon; B L Riggs
Journal:  J Bone Miner Res       Date:  1998-12       Impact factor: 6.741

Review 6.  Osteoporosis in Indians.

Authors:  N Malhotra; A Mithal
Journal:  Indian J Med Res       Date:  2008-03       Impact factor: 2.375

7.  Osteoporosis and osteopenia in India: a few more observations.

Authors:  Abraham Samuel Babu; Faizal M Ikbal; Manjula Sukumari Noone; Anupama Naomi Joseph; Prasanna Samuel
Journal:  Indian J Med Sci       Date:  2009-02

8.  Preliminary screening of osteoporosis and osteopenia in urban women from Jammu using calcaneal QUS.

Authors:  Sudhaa Sharma; Vishal R Tandon; Annil Mahajan; Avinash Kour; Dinesh Kumar
Journal:  Indian J Med Sci       Date:  2006-05

Review 9.  The Asia-Pacific Regional Audit-Epidemiology, Costs, and Burden of Osteoporosis in India 2013: A report of International Osteoporosis Foundation.

Authors:  Ambrish Mithal; Beena Bansal; Carey S Kyer; Peter Ebeling
Journal:  Indian J Endocrinol Metab       Date:  2014-07

10.  Osteoporosis treatment in India: Call for action.

Authors:  Premlata K Varthakavi; Ameya S Joshi; Nikhil M Bhagwat; Manoj D Chadha
Journal:  Indian J Endocrinol Metab       Date:  2014-07
View more
  5 in total

Review 1.  Screening Tools for Osteoporosis in India: Where Do We Place Them in Current Clinical Care?

Authors:  Kripa Elizabeth Cherian; Nitin Kapoor; Meeta Meeta; Thomas Vizhalil Paul
Journal:  J Midlife Health       Date:  2022-01-20

2.  Trabecular Bone Score and Bone Mineral Density in Postmenopausal Women with Morbid Obesity-A Clinical Paradox.

Authors:  Antresa Jose; Kripa Elizabeth Cherian; Munaf Babajan Nandyal; Stephen A Jiwanmall; Dheeraj Kattula; Thomas V Paul; Nitin Kapoor
Journal:  Med Sci (Basel)       Date:  2021-11-09

3.  Impact of teriparatide therapy in Indian postmenopausal women with osteoporosis with regard to DXA-derived parameters.

Authors:  Nandipati Venkata Sandeep; Aneez Joseph; Kripa Elizabeth Cherian; Nitin Kapoor; Thomas V Paul
Journal:  Ther Adv Endocrinol Metab       Date:  2022-07-26       Impact factor: 4.435

4.  Calcium deficiency worldwide: prevalence of inadequate intakes and associated health outcomes.

Authors:  Julie Shlisky; Rubina Mandlik; Sufia Askari; Steven Abrams; Jose M Belizan; Megan W Bourassa; Gabriela Cormick; Amalia Driller-Colangelo; Filomena Gomes; Anuradha Khadilkar; Victor Owino; John M Pettifor; Ziaul H Rana; Daniel E Roth; Connie Weaver
Journal:  Ann N Y Acad Sci       Date:  2022-03-05       Impact factor: 6.499

Review 5.  Non-medicalization of medical science: Rationalization for future.

Authors:  Madhukar Mittal; Parth Jethwani; Dukhabandhu Naik; M K Garg
Journal:  World J Methodol       Date:  2022-09-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.